These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7894097)

  • 1. In vitro activity of lithium succinate against Malassezia furfur.
    Nenoff P; Haustein UF; Münzberger C
    Dermatology; 1995; 190(1):48-50. PubMed ID: 7894097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifungal activity of a coal tar gel on Malassezia furfur in vitro.
    Nenoff P; Haustein UF; Fiedler A
    Dermatology; 1995; 191(4):311-4. PubMed ID: 8573928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of Malassezia furfur against rilopirox.
    Nenoff P; Haustein UF
    Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of topical lithium succinate in the treatment of seborrhoeic dermatitis.
    Leeming JP
    Dermatology; 1993; 187(2):149-50. PubMed ID: 8358107
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of topical lithium succinate in the treatment of seborrhoeic dermatitis.
    Cuelenaere C; De Bersaques J; Kint A
    Dermatology; 1992; 184(3):194-7. PubMed ID: 1392111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitation of free fatty acids generated by Malassezia - a possible explanation for the positive effects of lithium succinate in seborrhoeic dermatitis.
    Mayser P; Schulz S
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1384-9. PubMed ID: 27072777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium succinate and seborrhoeic dermatitis: an antifungal mode of action?
    Leeming JP; Burton JL
    Br J Dermatol; 1990 May; 122(5):718-9. PubMed ID: 2141277
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of anti-seborrhea substances against Pityrosporum ovale in vitro].
    Nenoff P; Haustein UF
    Hautarzt; 1994 Jul; 45(7):464-7. PubMed ID: 7928340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activity of the aqueous extract of Ilex paraguariensis against Malassezia furfur.
    Filip R; Davicino R; Anesini C
    Phytother Res; 2010 May; 24(5):715-9. PubMed ID: 19827026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro.
    Nenoff P; Haustein UF; Brandt W
    Skin Pharmacol; 1996; 9(6):388-94. PubMed ID: 9055360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
    Zissova LG; Kantarjiev TB; Kuzmanov AH
    Folia Med (Plovdiv); 2001; 43(3):10-2. PubMed ID: 11930825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls.
    Ashbee HR; Fruin A; Holland KT; Cunliffe WJ; Ingham E
    Exp Dermatol; 1994 Oct; 3(5):227-33. PubMed ID: 7881768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro anti-Malassezia activity and potential use in anti-dandruff formulation of Asparagus racemosus.
    Onlom C; Khanthawong S; Waranuch N; Ingkaninan K
    Int J Cosmet Sci; 2014 Feb; 36(1):74-8. PubMed ID: 24117781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.
    Roques C; Brousse S; Panizzutti C
    Mycopathologia; 2006 Dec; 162(6):395-400. PubMed ID: 17146583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Malassezia furfur.
    Schmidt A; Rühl-Hörster B
    Arzneimittelforschung; 1996 Apr; 46(4):442-4. PubMed ID: 8740097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521.
    Far FE; Al-Obaidi MMJ; Desa MNM
    J Mycol Med; 2018 Sep; 28(3):486-491. PubMed ID: 29753721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls.
    Ashbee HR; Ingham E; Holland KT; Cunliffe WJ
    Exp Dermatol; 1994 Jun; 3(3):106-12. PubMed ID: 7952921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibilities of
    Wang K; Cheng L; Li W; Jiang H; Zhang X; Liu S; Huang Y; Qiang M; Dong T; Li Y; Wang J; Feng S; Li H
    Heliyon; 2020 Jun; 6(6):e04203. PubMed ID: 32613106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. Efalith Multicenter Trial Group.
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):452-7. PubMed ID: 1532964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping by RAPD-PCR analyses of Malassezia furfur strains from pityriasis versicolor and seborrhoeic dermatitis patients.
    Gandra RF; Simão RC; Matsumoto FE; da Silva BC; Ruiz LS; da Silva EG; Gambale W; Paula CR
    Mycopathologia; 2006 Oct; 162(4):273-80. PubMed ID: 17039273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.